Sexual Functions and Covid-19

Sponsor

Gaziosmanpasa Research and Education Hospital (Other)

Overall Status

Completed

CT.gov ID

NCT05018065

Collaborator

(none)

101

Enrollment

Location

Arms

Actual Duration (Months)

12.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Sexual health is one the important components of life quality. The aim of this study is to compare sexual dysfunction of women who survived Covid-19 and who didn't undergo Covid-19.

Condition or Disease	Intervention/Treatment	Phase
Covid19 Sexual Behavior	Behavioral: Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)	N/A

Detailed Description

With identifying a new type of coronavirus, the infection disease known as Coronavirus disease-2019 (Covid-19) is still effective worldwide. Within the frame of the description that the health is "a complete physical, mental and social welfare," many physical and mental modality may be expected due to the pandemic and the measures against pandemic. Among them, sexual health is one of the basic indicative factors of human welfare. There are few data on sexual dysfunctions from the previous clinic pandemic experiences. From the very early stages of Covid-19 pandemic, health systems and researches focused on mortalities and short-term morbidities. Although there are similar studies about effects of pandemic on sexual behaviors of general community, there is no comparative study about the effects on sexual functions of women survived from Covid-19 and women having no Covid-19 history, yet. This study aims to compare women survived from Covid-19 and women having no Covid-19 history and having similar characteristics in terms of sexual dysfunctions.

Study Design

Study Type:

Interventional

Actual Enrollment :

101 participants

Allocation:

Non-Randomized

Intervention Model:

Crossover Assignment

Masking:

Single (Participant)

Primary Purpose:

Other

Official Title:

Evaluation of Women's Sexual Functions After Having Covid-19

Actual Study Start Date :

May 1, 2020

Actual Primary Completion Date :

Dec 1, 2020

Actual Study Completion Date :

Dec 30, 2020

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: 50 women previously diagnosed with mild - medium Covid-19 and had ambulatory care Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)	Behavioral: Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI) sexual dysfunction assesment
Active Comparator: 51 women having no Covid-19 history Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)	Behavioral: Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI) sexual dysfunction assesment

Arm

Intervention/Treatment

Active Comparator: 50 women previously diagnosed with mild - medium Covid-19 and had ambulatory care

Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

Behavioral: Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

sexual dysfunction assesment

Active Comparator: 51 women having no Covid-19 history

Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

Behavioral: Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

sexual dysfunction assesment

Outcome Measures

Primary Outcome Measures

Sexual function assesment of women previously diagnosed with mild - medium Covid-19 and comparision of results with helath women [6 months]
Sexual function assesment of women is done by using Female Sexual Functioning Index (FSFI).

Eligibility Criteria

Criteria

Ages Eligible for Study:

30 Years to 45 Years

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

previously diagnosed for mild - medium Covid-19 infection and had ambulatory care
being sexually active

Exclusion Criteria:

having psychiatric disease
having any malignity
having endometriosis
having a gynecologic surgery history
having a previous sexual dysfunction

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Saglık Bilimleri University Istanbul Gaziosmanpa Trainig and Research Hospital	Istanbul		Turkey

Sponsors and Collaborators

Gaziosmanpasa Research and Education Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Fatma ketenci gencer, Principle investigator, Gaziosmanpasa Research and Education Hospital

ClinicalTrials.gov Identifier:

NCT05018065

Other Study ID Numbers:

GaziosmanpasaTREHe

First Posted:

Aug 24, 2021

Last Update Posted:

Aug 27, 2021

Last Verified:

Jan 1, 2021

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

COVID-19

Study Results

No Results Posted as of Aug 27, 2021